期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

CEAG方案治疗低增生性MDS-RAEB和AML的临床观察 被引量：3

Clinical observation of therapeutic effect of hypo-proliferative MDS-RAEB with CEAG
下载PDF
导出
摘要 目的观察CEAG方案对低增生性骨髓增生异常综合征-难治性贫血伴原始细胞增多(MDS-RAEB)和急性髓细胞白血病治疗(AML)的疗效和安全性。方法对44例低增生性MDS-RAEB和AML住院患者进行CEAG方案诱导缓解治疗。结果 CEAG方案诱导缓解治疗低增生性MDS-RAEB和AML有效且安全。 Objective To investigate the efficacy and safety of chemotherapy with CEAG（cytarabine,etoposide,aclarubicin and granulocyte colony-stimulating factor） regimen on patients with low hyperplastic myelodysplastic-syndrome—RAEB（MDS-RAEB） and acute myeloid leukemia（AML）.Methods The patients with low hyperplastic MDS-RAEB and AML（n=44） were treated with CEAG regimen as induction therapy.Results CEAG regimen treatment as remission induction chemotherapy in patients with Low hyperplastic MDS-RAEB and AML was effective.
作者 李云龙 张曦 陈幸华 高蕾 文钦 曾蕴璟 刘嘉 罗晓庆
机构地区 第三军医大学新桥医院血液内科
出处 《西部医学》 2010年第7期1219-1220,1223,共3页 Medical Journal of West China
关键词 低增生性 骨髓增生异常综合征-难治性贫血伴原始细胞增多 急性髓细胞白血病 CEAG Low hyperplastic Myelodysplastic syndrome-RAEB Acute myeloid leukemia CEAG
分类号 R733.3 [医药卫生—肿瘤]
  • 相关文献

参考文献8

  • 1Higashi Y, Turzanski J, Pallis M, et al. Contrasting in vitro effects for the combination of fludarabine, cytosine (Ara-c) and granul ocyte colonys timulating factor(FLAG) compared with daunorubicin and Ara-c in Pglycop rote inpositive and P- glycop rote innegative acutemyeloblastic leukemia[J]. Br J Haematol, 2000,111 : 565-569.
  • 2Yamada K, Furusawa S, Saito K, et al. Concurrent use of granulocyte colony stimulating factor with low dose cytosine arabinoside and aclarubingcin for previously treated acute myelogenous leukemia:a pilot study[J]. Leukamia,1995,9(1):10-14.
  • 3Katagiri T, Miyazawa K, Nishimaki J, et al. Combination of granulocyte conony stiimulating factor and low dose cytosine arabino side further enhances myeloid differentitation in leukemia cells in vitro, leukemia cells in vitro[J]. Leuk Lymphoma,2000, 39 (1-2) : 173-184.
  • 4郝玉书,徐世荣.骨髓增生异常综合征与白血病前期[J].中华血液学杂志,2000,21(4):173-173. 被引量：17
  • 5Estey E H. Treatment of acute myelogenous leckemia and myelodys plastic syndromes[J]. Semin Hematol, 1995,32(2) : 132.
  • 6胡学琼,李一辉,王兴.CAG方案治疗骨髓增生异常综合征疗效观察[J].华北煤炭医学院学报,2008,10(3):357-358. 被引量：1
  • 7Anderson JE, Kopecky KJ, Willman CL, et al. Outcome fter induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposid compared to cytarabine and daunorubicin: a Southwest Oncology Groupstudy [J] . Blood,2002,100(12) :3836-3876.
  • 8Saito K,Nakamura Y,Aoyagi M,et al. Low- dose cytarabine and aclarubicin in combination with granulocyte colony stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML,and refractory anemia with excess blasts in transformation [J]. Int J Hematol,2000,71(3) :238- 244.

二级参考文献2

  • 1[2]Hansen PB,Penkowa M,Johnsen HE.Hematopoietic growthfactors fur the treatment of myelodysplastic syndromes[J].Leuk Lymphoma,1998,28(5-6):491
  • 2[3]Katagiri T,Miyazawa K,Nishimaki J,et al.Combination of granulo-cyte conony stimulating factor and Low-dose cytosine arabinoside further enhances myecoid differentitation in leukemia cells in vitro.Leukemia cells in vitro[J].Leuk Lymphoma,2000,39(1-2):173

共引文献16

同被引文献18

引证文献3

二级引证文献9

西部医学
2010年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部